171 related articles for article (PubMed ID: 25773808)
1. Preparation and characterization of anti-GP73 monoclonal antibodies and development of double-antibody sandwich ELISA.
Li QW; Chen HB; Li ZY; Shen P; Qu LL; Gong LL; Xu HP; Pang L; Si J
Asian Pac J Cancer Prev; 2015; 16(5):2043-9. PubMed ID: 25773808
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis.
Zhang Y; Xi Y; Fang J; Luo S; Wilson JJ; Huang RP
J Immunoassay Immunochem; 2016; 37(4):390-406. PubMed ID: 27088654
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody preparation of Golgi phosphoprotein 2 and preliminary application in the early diagnosis of hepatocellular carcinoma.
Ju Q; Zhao Y; Liu Y; Zhou G; Li F; Xie P; Li Y; Li GC
Mol Med Rep; 2013 Aug; 8(2):517-22. PubMed ID: 23727927
[TBL] [Abstract][Full Text] [Related]
4. [Development of a quantitative serum assay of Golgi protein 73 in hepatocellular carcinoma using xMAP technology].
Wu Y; Wang YP; Ma J; Zhang YH; Sun HQ; Sun JP; Wang ZK; Xu J; Dai YC; Li N
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):351-356. PubMed ID: 31137168
[No Abstract] [Full Text] [Related]
5. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
[TBL] [Abstract][Full Text] [Related]
6. Value of Golgi protein 73 monoclonal antibody in diagnosis of hepatocellular carcinoma.
Wang C; Hua-yu Y; Yi-lei M; Jin-chun Z; Hai-feng X; Gui-yong J; Yan-ling J; Xin-xin C; Xin L; Xin-ting S; Hong-bing Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Feb; 33(1):39-44. PubMed ID: 21375936
[TBL] [Abstract][Full Text] [Related]
7. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population.
Hu JS; Wu DW; Liang S; Miao XY
Med Oncol; 2010 Jun; 27(2):339-45. PubMed ID: 19399652
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a magnetic particles-based chemiluminescence enzyme immunoassay for Golgi protein 73 in human serum.
Liu X; Wan X; Lu S; Zhang L; Yu S; Lu X
Clin Chim Acta; 2015 May; 445():54-9. PubMed ID: 25801213
[TBL] [Abstract][Full Text] [Related]
9. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
Zhao XY; Li N; Ding HG; Jiang FF
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and expression of serum Golgi protein 73 in primary hepatocellular carcinoma.
Jiao C; Cui L; Piao J; Qi Y; Yu Z
J Cancer Res Ther; 2018; 14(6):1239-1244. PubMed ID: 30488837
[TBL] [Abstract][Full Text] [Related]
11. Detection of Hepatocellular Carcinoma Biomarker Golgi Protein 73 Based on Magnetic Enzyme-Linked Immunoassay.
Xia Y; Li Q; Gong L; Xu H; Pang L; Li Z; Si J
J Nanosci Nanotechnol; 2017 Jan; 17(1):231-7. PubMed ID: 29620331
[TBL] [Abstract][Full Text] [Related]
12. [Cloning and expressing of golgi protein73 gene fragment and preparation of monoclonal antibodies against the recombinant protein].
Guo JX; Wei HS; Song YJ; Zhao J; Liu AX; Liu J; Chen L; Xu J; Li BA; Mao YL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Aug; 27(4):301-3. PubMed ID: 24579482
[TBL] [Abstract][Full Text] [Related]
13. [Value of combined detection of GP73 and alpha-fetoprotein in diagonosis of hepatocellular carcinoma].
Wu QP; Xie FY; Meng QL; Mu YY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr; 26(2):148-9. PubMed ID: 23002561
[TBL] [Abstract][Full Text] [Related]
14. Development of an alpha-fetoprotein and Golgi protein 73 multiplex detection assay using xMAP technology.
Wu Y; Ma J; Wang Y; Zhang Y; Hou Y; Zhang C; Sun H; Sun J; Wang Z; Li N
Clin Chim Acta; 2018 Jul; 482():209-214. PubMed ID: 29630871
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of an anti-GP73 monoclonal antibody for immunoblotting and sandwich ELISA.
Zhang A; Cao B
J Biomed Res; 2012 Nov; 26(6):467-73. PubMed ID: 23554786
[TBL] [Abstract][Full Text] [Related]
16. Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases.
Tian L; Wang Y; Xu D; Gui J; Jia X; Tong H; Wen X; Dong Z; Tian Y
Int J Cancer; 2011 Oct; 129(8):1923-31. PubMed ID: 21140449
[TBL] [Abstract][Full Text] [Related]
17. [Generation of monoclonal antibody to GP73 based on antigen epitope].
Yao XN; Huo JR; Liu YF; Liu BC; Wu F; Fan GC; Wang QM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):663-6. PubMed ID: 20619090
[TBL] [Abstract][Full Text] [Related]
18. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
Marrero JA; Romano PR; Nikolaeva O; Steel L; Mehta A; Fimmel CJ; Comunale MA; D'Amelio A; Lok AS; Block TM
J Hepatol; 2005 Dec; 43(6):1007-12. PubMed ID: 16137783
[TBL] [Abstract][Full Text] [Related]
19. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
20. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
